Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase ...

The following is a summary of “Prolyl Endopeptidase Is Involved in Filaggrinolysis and Cornification,” published in the January 2025 issue of Dermatology by Briot et al. FLG is a key biomarker for ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase, is strongly induced in ...

ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.

Stock analysts at HC Wainwright issued their FY2029 earnings estimates for Akebia Therapeutics in a research note issued on ...

Vafseo ® (vadadustat) is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to treat anemia due ...

Turkish drugmaker Er-Kim has signed a distribution agreement with Germany’s MEDICE Health Family to commercialize Vafseo ...

The global anemia treatment market was valued at USD 10.0 billion in 2022 and is expected to grow to USD 14.9 billion by 2028 ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

like post-translational modifications such as prolyl hydroxylation and phosphorylation, it has different roles in different contexts. The formation of 5-methylcytosine from cytosine is a well ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.